Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration

Keyphrases

• Neurotoxicity 100%
• Phencyclidine 100%
• Pharmacological Characterization 100%
• Locomotor Sensitization 100%
• Clozapine 66%
• 5-HT2 66%
• Sulpiride 66%
• SCH23390 66%
• Behavioral Sensitization 33%
• Attenuation 33%
• Muscarinic Receptors 33%
• Serotonin 33%
• High Dose 33%
• Risperidone 33%
• AMPA Receptor (AMPAR) 33%
• Aminobutyric Acid 33%
• Sodium 33%
• Neuronal Death 33%
• Atropine 33%
• Haloperidol 33%
• Kainate 33%
• 3-dione 33%
• Ketanserin 33%
• Locomotor Activity 33%
• Barbital 33%
• D2 Receptor 33%
• Once a Day 33%
• Vacuolization 33%
• 5-HT2 Receptor 33%
• Locomotor Activation 33%
• Complex Pathways 33%
• Non-identity 33%

Neuroscience

• Neurotoxicity 100%
• Phencyclidine 100%
• Clozapine 66%
• Sulpiride 66%
• Levosulpiride 66%
• 5-HT2 Antagonists 66%
• Neuroapoptosis 33%
• Serotonin 33%
• Gamma-Aminobutyric Acid 33%
• AMPA Receptor 33%
• AMPA 33%
• Locomotor Activity 33%
• Muscarinic Acetylcholine Receptor 33%
• Risperidone 33%
• Barbital 33%
• 5-HT2 Receptor 33%
• DNQX 33%
• Haloperidol 33%
• Ketanserin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neurotoxicity 100%
• Phencyclidine 100%
• Clozapine 66%
• Sulpiride 66%
• Serotonin 2 Antagonist 66%
• Muscarinic Receptor 33%
• Serotonin 33%
• 4 Aminobutyric Acid 33%
• Risperidone 33%
• Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid 33%
• AMPA Receptor 33%
• Kainic Acid 33%
• 4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol 33%
• Ketanserin 33%
• 6,7 Dinitro 2,3 Quinoxalinedione 33%
• Barbital 33%